Duration: 45 minutes
Presenter: Joshua Hayden, Ph.D., DABCC, FADLM
Sponsor: Abbott Diagnostics
Cost: Free
Hemolysis remains the leading cause of sample cancellation in most clinical laboratories. This issue is largely, and in many ways correctly, thought to be a collection problem.
Clinical laboratories devote significant time and effort trying to reinforce good phlebotomy practices in an ongoing struggle to keep hemolysis rates low. While collection remains essential, this talk will focus on the wide array of factors that are almost entirely within the clinical laboratory’s control and have been shown to reduce the rate of samples cancelled due to hemolysis.
Attendees will be given an overview of laboratory-based initiatives that can reduce the cancellation of samples due to hemolysis. At the conclusion of this seminar, attendees should be able to:
- Justify the value of reducing the number of samples cancelled due to hemolysis
- Outline the factors within their control that can reduce sample hemolysis
- Construct approaches to managing hemolyzed samples that do not require cancellation
Continuing education credit will be offered for this session.
Presented by

Joshua Hayden, Ph.D., DABCC, FADLM
Section Head
Clinical Biochemistry
Cleveland Clinic Laboratories
Supported in part through an unrestricted educational grant by:


